{"cluster": 65, "subcluster": 0, "abstract_summ": "To better understand antibody responses induced by spike protein-based vaccines, we performed a qualitative study by immunizing rabbits with various SARS-CoV-2 spike protein antigens: S-ectodomain (S1+S2) (aa 16-1213), which lacks the cytoplasmic and transmembrane domains (CT-TM), the S1 domain (aa 16-685), the receptor-binding domain (RBD) (aa 319-541), and the S2 domain (aa 686-1213, lacking the RBD, as control).Synthetic Fab construct BCR type antibody IgG (CR5840) had shown Polyspecific binding activity with spike glycoprotein when compared with available Anti-SARS antibody CR3022.Thus we propose CR5840 Fab constructed antibody as potential neutralizing antibody for SARS-CoV-2.Here, we first studied T cell responses to structural (nucleocapsid protein, NP) and non-structural (NSP-7 and NSP13 of ORF1) regions of SARS-CoV-2 in convalescent from COVID-19 (n=24).In summary, in this descriptive, preliminary study we showed that SARS-CoV-2-reactive IFN-\u03b3 CD8+ T cells can be detected in a non-negligible percentage of patients with moderate to severe forms of COVID-19.To better understand antibody response induced by spike protein-based vaccines, we immunized rabbits with various SARS-CoV-2 spike protein antigens: S-ectodomain (S1+S2) (aa 16-1213), which lacks the cytoplasmic and transmembrane domains (CT-TM), the S1 domain (aa 16-685), the receptor-binding domain (RBD) (aa 319-541), and the S2 domain (aa 686-1213 as control).", "title_summ": "An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoproteinJunctional and somatic hypermutation-induced CX(4)C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibodySARS-CoV-2-reactive interferon-\u03b3-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019.SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptorsComputational methods to develop potential neutralizing antibody Fab region against SARS-CoV-2 as therapeutic and diagnostic toolThe SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severityDifferent pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individualsHigh seroreactivity against SARS-CoV-2 Spike epitopes in a pre SARS-CoV-2 cohort: implications for antibody testing and vaccine designShared Antigen-specific CD8+ T cell Responses Against the SARS-COV-2 Spike Protein in HLA A*02:01 COVID-19 ParticipantsStructure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralizationAntibody repertoire induced by SARS-CoV-2 spike protein immunogensCharacterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirusTwo linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patientsCharacterization of novel monoclonal antibodies against MERS-coronavirus spike proteinTargets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individualsAntibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits", "title_abstract_phrases": "To better understand antibody responses induced by spike protein-based vaccines, we performed a qualitative study by immunizing rabbits with various SARS-CoV-2 spike protein antigens: S-ectodomain (S1+S2) (aa 16-1213), which lacks the cytoplasmic and transmembrane domains (CT-TM), the S1 domain (aa 16-685), the receptor-binding domain (RBD) (aa 319-541), and the S2 domain (aa 686-1213, lacking the RBD, as control).Importantly, we detected SARS-CoV-2\u2212reactive CD4+ T cells in \u223c40-60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating \u2018common cold\u2019 coronaviruses and SARS-CoV-2.Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbitsMultiple vaccine candidates against SARS-CoV-2 based on viral spike protein are under development.Here, we first studied T cell responses to structural (nucleocapsid protein, NP) and non-structural (NSP-7 and NSP13 of ORF1) regions of SARS-CoV-2 in convalescent from COVID-19 (n=24).In summary, in this descriptive, preliminary study we showed that SARS-CoV-2-reactive IFN-\u03b3 CD8+ T cells can be detected in a non-negligible percentage of patients with moderate to severe forms of COVID-19.To better understand antibody response induced by spike protein-based vaccines, we immunized rabbits with various SARS-CoV-2 spike protein antigens: S-ectodomain (S1+S2) (aa 16-1213), which lacks the cytoplasmic and transmembrane domains (CT-TM), the S1 domain (aa 16-685), the receptor-binding domain (RBD) (aa 319-541), and the S2 domain (aa 686-1213 as control)."}